A Temperature of 40 °C Appears to be a Critical Threshold for Potentiating Cytotoxic Chemotherapy In Vitro and in Peritoneal Carcinomatosis Patients Undergoing HIPEC

Cytoreductive Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study

(2014) J. Spiliotis et al.   ANNALS OF SURGICAL ONCOLOGY

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of advanced epithelial ovarian carcinoma: Upfront therapy, at first recurrence, or later?

(2013) L. Gonzalez Bayon et al.   EJSO

Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials

(2013) F. Coccolini et al.   EJSO

Effects of bevacizumab and hyperthermia in a rodent model of hyperthermic intraperitoneal chemotherapy (HIPEC)

(2013) Johanna Verhulst   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer: a multi-institutional study

(2012) M Deraco et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Summary of current therapeutic options for peritoneal metastases from colorectal cancer

(2012) Terence C. Chua et al.   JOURNAL OF SURGICAL ONCOLOGY

Intraoperative hyperthermic versus postoperative normothermic intraperitoneal chemotherapy for colonic peritoneal carcinomatosis: a case-control study

(2011) P. H. Cashin et al.   ANNALS OF ONCOLOGY

Evaluation of Best Supportive Care and Systemic Chemotherapy as Treatment Stratified according to the retrospective Peritoneal Surface Disease Severity Score (PSDSS) for Peritoneal Carcinomatosis of Colorectal Origin

(2011) Joerg OW Pelz et al.   BMC CANCER

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multi-institutional phase-II trial

(2011) Marcello Deraco et al.   GYNECOLOGIC ONCOLOGY

Apoptotic and necrotic effects of tumour necrosis factor-alpha potentiated with hyperthermia on L929 and tumour necrosis factor-alpha-resistant L929

(2010) Philip C. W. Lui et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Prospective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases

(2010) Robert T Ripley et al.   Trials

Mesothelioma Cells Escape Heat Stress by Upregulating Hsp40/Hsp70 Expression via Mitogen-Activated Protein Kinases

(2009) Michael Roth et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results

(2009) Terence C. Chua et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer

(2008) Vic J. Verwaal et al.   ANNALS OF SURGICAL ONCOLOGY

Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin

(2008) Dominique Elias et al.   JOURNAL OF CLINICAL ONCOLOGY